ISRCTN00525237已完成不适用
An international multicentre randomised trial comparing general anaesthetic versus local anaesthetic for carotid surgery
The Health Foundation (UK)0 个研究点目标入组 3,526 人开始时间: 2002年9月12日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,526
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •The main criterion for entry into this study is that, in the opinion of the responsible clinician, the patient requiring an endarterectomy is suitable for either local or general anaesthesia, and there is no clear indication for either type. All patients with either symptomatic or asymptomatic internal carotid stenosis for whom surgery is advised are eligible. There is no upper age limit.
排除标准
- •1. Failure to obtain informed consent
- •2. Patient unable to co-operate with awake testing during local anaesthesia
- •3. Patient considered unfit for general anaesthesia
- •4. Patient considered unfit for local anaesthesia
- •5. Patient requiring simultaneous bilateral carotid endarterectomy
- •6. Carotid endarterectomy combined with another operative artery bypass surgery
- •7. Patient has been randomised into the trial previously
研究者
相似试验
已完成
不适用
A multicentre international randomised trial to evaluate percutaneous endoscopic gastrostomy (PEG) and nasogastric (NG) tube feeding in patients admitted to hospital with a recent strokeCirculatory SystemStrokeISRCTN65375365Department of Health (UK)4,023
已完成
不适用
ACCURE-UK 2: the effects of appendix removal on ulcerative colitisUlcerative colitislcerative colitisDigestive SystemISRCTN60945764niversity of Birmingham202
进行中（未招募）
不适用
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-013884-21-DEEnceladus Pharmaceuticals BV90
进行中（未招募）
1 期
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)EUCTR2009-013884-21-BEEnceladus Pharmaceuticals BV90
进行中（未招募）
不适用
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-013884-21-PLEnceladus Pharmaceuticals BV90